Inventor · disambiguated record
Friedrich-Johannes Kammerer
Also filed as: KAEMMERER FRIEDRICH-JOHANNES
11 granted patents·357 citations·filing 1979–1996
93Inventor score
Files withHOECHST AG11
Top patents by PatentIndex Score
11 records- 0196US4284786A5-Methylisoxazole-4-carboxylic-(4-trifluoromethyl)-anilideHOECHST AG·Filed 1979·Granted Aug 18, 1981·81 cites·1 claims
- 0293US5494911AIsoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their useHOECHST AG·Filed 1990·Granted Feb 27, 1996·61 cites·22 claims
- 0393US4351841APharmaceutical preparation and method of treatmentHOECHST AG·Filed 1981·Granted Sep 28, 1982·45 cites·2 claims
- 0489US5679709AMedicaments to combat autoimmune diseasesHOECHST AG·Filed 1995·Granted Oct 21, 1997·32 cites·8 claims
- 0584US5532259AIsoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their useHOECHST AG·Filed 1995·Granted Jul 2, 1996·32 cites·18 claims
- 0675US4965276AMedicaments to combat chronic graft-versus-host diseasesHOECHST AG·Filed 1986·Granted Oct 23, 1990·47 cites·10 claims
- 0769US5268382AMedicaments to combat autoimmune diseases, in particular systemic lupus erythematosusHOECHST AG·Filed 1992·Granted Dec 7, 1993·27 cites·10 claims
- 0864US4636513AIsoxazole derivatives and medicaments containing these compoundsHOECHST AG·Filed 1985·Granted Jan 13, 1987·11 cites·9 claims
- 0953US5459163AMedicament to combat autoimmune diseasesHOECHST AG·Filed 1993·Granted Oct 17, 1995·15 cites·1 claims
- 1042US4258046APyrano-heterocycles and medicaments containing these compoundsHOECHST AG·Filed 1979·Granted Mar 24, 1981·2 cites·5 claims
- 1141US5714514A2-Cyano-3-mercaptocrotonamidesHOECHST AG·Filed 1996·Granted Feb 3, 1998·4 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Friedrich-Johannes Kammerer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →